Repeated infusions of anti-TNF-alpha chimeric antibody (cA2) maintain remission in refractory Crohn's disease

被引：0
|
作者：
DHaens, G
Rutgeerts, P
vanDeventer, SJH
Present, DH
Mayer, L
Hanauer, SB
Braakman, TAJ
DeWoody, KL
Schaible, TF
Targan, SR
机构：
[1] UZ GASTHUISBERG,LOUVAIN,BELGIUM
[2] AMC,AMSTERDAM,NETHERLANDS
[3] UNIV CHICAGO,CHICAGO,IL 60637
[4] CENTOCOR INC,MALVERN,PA 19355
[5] CEDARS SINAI MED CTR,LOS ANGELES,CA 90048
来源：
GUT | 1997年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A68 / A69
页数：2
相关论文
共 50 条
  • [1] Retreatment with anti-TNF-alpha chimeric antibody (cA2) effectively maintains cA2-induced remission in Crohn's disease.
    Rutgeerts, P
    DHaens, G
    vanDeventer, SJH
    Present, DH
    Mayer, L
    Hanauer, SB
    Braakman, TAJ
    DeWoody, KL
    Schaible, TF
    Targan, SR
    GASTROENTEROLOGY, 1997, 112 (04) : A1078 - A1078
  • [2] CHIMERIC ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY CA2 BINDS RECOMBINANT TRANSMEMBRANE TNF-ALPHA AND ACTIVATES IMMUNE EFFECTOR FUNCTIONS
    SCALLON, BJ
    MOORE, MA
    TRINH, H
    KNIGHT, DM
    GHRAYEB, J
    CYTOKINE, 1995, 7 (03) : 251 - 259
  • [3] A multicenter trial of cA2 anti-TNF chimeric monoclonal antibody in patients with active Crohn's disease.
    McCabe, RP
    Woody, J
    vanDeventer, S
    Targan, SR
    Mayer, L
    vanHogezand, R
    Rutgeerts, P
    Hanauer, SB
    Podolsky, D
    Elson, CO
    GASTROENTEROLOGY, 1996, 110 (04) : A962 - A962
  • [4] POTENTIAL CLINICAL RELEVANCE OF THE MECHANISM OF INHIBITION OF IMMUNE FUNCTION BY THE MOUSE-HUMAN CHIMERIC ANTI-TNF-ALPHA ANTIBODY, CA2
    DALESANDRO, MB
    KINNEY, CS
    FREDERICK, B
    JORDAN, RE
    GHRAYEB, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1484 - 1484
  • [5] Certolizumab pegol - A pegylated anti-TNF-alpha antibody fragment for the treatment of Crohn's disease
    Schlesselman, Lauren S.
    FORMULARY, 2008, 43 (01) : 22 - 28
  • [6] SYSTEMATIC REVIEW: THE CLINICAL EFFECTIVENESS OF ANTI-TNF-ALPHA DRUGS IN ADULTS WITH REFRACTORY CROHN'S DISEASE
    Assasi, N.
    Blackhouse, G.
    Xie, F.
    Marshall, J. K.
    Irvine, J.
    Gaebel, K.
    Robertson, D.
    Campbell, K.
    Hopkins, R.
    Goeree, R.
    VALUE IN HEALTH, 2009, 12 (07) : A346 - A346
  • [7] Chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease -: Reply
    Targan, SR
    Schaible, TF
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 334 - 334
  • [8] A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
    Targan, SR
    Hanauer, SB
    vanDeventer, SJH
    Mayer, L
    Present, DH
    Braakman, T
    DeWoody, KL
    Schaible, TF
    Rutgeerts, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15): : 1029 - 1035
  • [9] Does Anti-TNF-Alpha Therapy Affect the Morphology of Crohn's Disease?
    Schaeffer, David F.
    Walsh, Joanna
    Kirsch, Richard
    Waterman, Matti
    Silverberg, Mark S.
    Riddell, Robert H.
    GASTROENTEROLOGY, 2012, 142 (05) : S386 - S386
  • [10] Treatment of severe steroid refractory acute graft versus host disease with Infliximab, a chimeric human/mouse anti-TNF-alpha antibody
    Kobbe, G
    Schneider, P
    Fenk, R
    Rohr, U
    Neumann, F
    Aivado, M
    Rong, A
    Hünerlitürkoglu, A
    Haas, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S180 - S180
12345